Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fusidic acid vs injected PRF after fractional CO2 laser
IRCT20250630066301N2Phase 4Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Aug 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of fusidic acid and platelet rich fibrin in Post-inflammatory hyperpigmentation (PIH), Hypertrophic Scar (HS), erythema and 1 more (2 arms), sponsored by Mashhad University of Medical Sciences. Started Aug 2025; status: completed.
02
Drugs
fusidic acidplatelet rich fibrin
03
Conditions
Post-inflammatory hyperpigmentation (PIH)Hypertrophic Scar (HS)erythemasurgical site infection (SSI)
Beyond the preview
Go deeper on IRCT20250630066301N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250630066301N2.